Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-0965 ◽

2016 ◽

Vol 22 (11) ◽

pp. 2675-2683 ◽

Author(s):

Sibylle Loibl ◽

Silvia Darb-Esfahani ◽

Jens Huober ◽

Alexander Klimowicz ◽

Jenny Furlanetto ◽

...

Keyword(s):

Breast Cancer ◽

Protein Expression ◽

Integrated Analysis ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract P2-09-27: Integrated analysis of PTEN protein expression and PI3KCA mutations as predictors for pathological complete response in HER2-positive breast cancer

10.1158/1538-7445.sabcs17-p2-09-27 ◽

2018 ◽

Author(s):

J Gavila ◽

F Gozalbo ◽

MA Climent ◽

AL Guerrero ◽

S Sandiego ◽

...

Keyword(s):

Breast Cancer ◽

Protein Expression ◽

Pathological Complete Response ◽

Complete Response ◽

Integrated Analysis ◽

Her2 Positive ◽

Pten Protein ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Cancer Management and Research ◽

10.2147/cmar.s278694 ◽

2020 ◽

Vol Volume 12 ◽

pp. 12715-12722

Author(s):

Hui Yan ◽

Hui Xiao ◽

Jiujun Zhu ◽

Jingyang Zhang ◽

Zhenzhen Liu

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Protein Expression ◽

Expression Level ◽

Protein Expression Level ◽

Her2 Positive ◽

Her2 Protein ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer

10.1158/1538-7445.sabcs16-s3-05 ◽

2017 ◽

Author(s):

M Tanioka ◽

C Fan ◽

LA Carey ◽

T Hyslop ◽

BN Pitcher ◽

...

Keyword(s):

Breast Cancer ◽

Genomic Data ◽

Phase Iii ◽

Weekly Paclitaxel ◽

Integrated Analysis ◽

Her2 Positive ◽

Phase Iii Trial ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-3431 ◽

2018 ◽

Vol 24 (21) ◽

pp. 5292-5304 ◽

Author(s):

Maki Tanioka ◽

Cheng Fan ◽

Joel S. Parker ◽

Katherine A. Hoadley ◽

Zhiyuan Hu ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Iii ◽

Integrated Analysis ◽

Her2 Positive ◽

Phase Iii Trial ◽

Her2 Positive Breast Cancer ◽

Predictors Of Response ◽

Rna And Dna ◽

Positive Breast Cancer

Download Full-text

Abstract 3377: Simultaneous analysis of the mutational landscape and RNA and protein expression profile of HER2-positive breast cancer using 3D BiologyTM

10.1158/1538-7445.am2017-3377 ◽

2017 ◽

Author(s):

Sarayna Chumsri ◽

Daniel J. Serie ◽

Brian M. Necela ◽

Jennifer M. Kachergus ◽

Bianca C. Axenfeld ◽

...

Keyword(s):

Breast Cancer ◽

Protein Expression ◽

Expression Profile ◽

Simultaneous Analysis ◽

Protein Expression Profile ◽

Her2 Positive ◽

Mutational Landscape ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

P5-13-11: PTEN and Tau-Protein Expression: Predictive Value of Poor Response to Trastuzumab Plus Paclitaxel in Patients with HER2−Positive Breast Cancer.

10.1158/0008-5472.sabcs11-p5-13-11 ◽

2011 ◽

Author(s):

DH Koo ◽

J-H Ahn ◽

DH Yoon ◽

S-B Kim ◽

HJ Lee ◽

...

Keyword(s):

Breast Cancer ◽

Protein Expression ◽

Tau Protein ◽

Predictive Value ◽

Poor Response ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Review of treatment strategies for HER2 positive breast cancer and their implementation in a major Swiss hospital

10.1055/s-0040-1710671 ◽

2020 ◽

Author(s):

F Geissler ◽

M Vetter ◽

A Schoetzau ◽

C Montavon ◽

C Kurzeder ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Strategies ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines

10.26226/morressier.5b4709836f4cb30010951ad8 ◽

2018 ◽

Author(s):

Gloria Peiro Cabrera

Keyword(s):

Breast Cancer ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Breast Cancer Cell Lines ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Id Proteins ◽

Positive Breast Cancer Cell ◽

Positive Breast Cancer

Download Full-text

FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer

Case Medical Research ◽

10.31525/cmr-24bd324 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text